PET-CT显像、基因组特征与接受免疫治疗的 头颈癌患者生存
Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2021-01-01
本研究分析头颈癌患者接受免疫检查点抑制剂治疗时,正电子发射断层扫描-计算机断层扫描(PET-CT)最大标准化摄取值与生存之间的关联。摘要未提供具体样本量、数值结果或结论。
要点
- 研究关注PET-CT最大标准化摄取值与免疫治疗头颈癌患者生存的关联。
- 摘要未报告具体阈值、效应量或统计学显著性。
- 基因组特征与生存的关联在摘要中未给出具体结果。
原文
This study analyzes the association between maximum standardized uptake value on positron emission tomography–computed tomography and survival in patients with head and neck cancer who are receiving immune checkpoint inhibitor drugs.
来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。
引用
- Fitzgerald CWR, Valero C, Swartzwelder CE, et al. Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34297796. doi:10.1001/jamaoto.2021.1763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。